Medicare Enrolled

Dr. Scott Caesar, MD

Urology Physician · Fort Myers, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
8931 COLONIAL CENTER DR, Fort Myers, FL 33905
2394581196
In practice since 2009 (16 years)
NPI: 1083849566 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Caesar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Caesar? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Caesar

Dr. Scott Caesar is an urology physician in Fort Myers, FL, with 16 years of NPI registration. Based on federal Medicare data, Dr. Caesar performed 7,601 Medicare services across 4,852 unique beneficiaries.

Between the years covered by Open Payments, Dr. Caesar received a total of $19,400 from 55 pharmaceutical and/or device companies across 422 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Caesar is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice ▲ Top 16% volume in FL $19,400 industry payments

Medicare Practice Summary

Medicare Utilization ↗
7,601
Medicare services
Top 16% in FL for urology physician
4,852
Unique beneficiaries
$57
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~475 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Automated urinalysis 2,076 $2 $10
Office visit, established patient (20-29 min) 1,514 $65 $226
Office visit, established patient (30-39 min) 929 $92 $335
Bladder ultrasound after voiding 670 $8 $65
Office visit, established patient (10-19 min) 338 $41 $136
Leuprolide acetate (for depot suspension), 7.5 mg 316 $136 $685
Diagnostic exam of bladder and urethra using an endoscope 269 $183 $705
Hospital follow-up visit, moderate complexity 177 $65 $227
New patient office visit (30-44 min) 133 $78 $342
Insertion of implant in urethra within prostate gland using an endoscope, each additional implant 129 $42 $204
Insertion of lower leg neurostimulator electrode 99 $90 $419
New patient office visit (45-59 min) 99 $121 $526
Simple change of bladder tube 95 $75 $373
Hospital follow-up visit, low complexity 89 $41 $132
Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and 80 $42 $173
Simple insertion of temporary bladder tube 79 $49 $252
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle 67 $27 $113
Electronic assessment of bladder emptying 55 $6 $141
Ultrasound scan of pelvic region through rectum 51 $110 $458
New patient office or other outpatient visit, 15-29 minutes 44 $47 $233
Insertion of implant in urethra within prostate gland using an endoscope, 1 implant 37 $166 $768
Ultrasonic guidance for needle placement 34 $22 $641
Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope 30 $261 $839
Shock wave crushing of kidney stones 28 $467 $1,948
Biopsy of prostate gland 26 $90 $481
Initial hospital admission, moderate complexity 23 $98 $440
Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm 19 $229 $1,003
Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm 17 $580 $2,463
Insertion of peripheral or gastric neurostimulator generator 14 $125 $564
Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings 13 $26 $672
Insertion of device into abdomen with pressure and urine flow rate study 13 $155 $439
Complete laser vaporization of prostate including control of bleeding using an endoscope 13 $556 $2,382
Injection procedure to cause erection 13 $58 $307
Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies 12 $275 $1,089
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.4% high complexity
10.9% medium
88.7% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$19,400
Total received (2018-2024)
Avg $2,771/year across 7 years
Top 12% in FL for urology physician
55
Companies
422
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,364 (79.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$3,707 (19.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$329 (1.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,542
2023
$3,273
2022
$4,294
2021
$3,828
2020
$970
2019
$3,139
2018
$2,353

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Teleflex LLC
$6,144
NeoTract Inc.
$2,328
Janssen Biotech, Inc.
$1,290
Boston Scientific Corporation
$1,188
Valencia Technologies Corporation
$1,001
Laborie Medical Technologies Corp.
$822
Coloplast Corp
$661
Axonics, Inc.
$608
Astellas Pharma US Inc
$571
Endo Pharmaceuticals Inc.
$504
PROCEPT BioRobotics Corporation
$383
C. R. Bard, Inc. & Subsidiaries
$366
Bayer Healthcare Pharmaceuticals Inc.
$340
Augmenix, Inc.
$298
Medtronic USA, Inc.
$273
PFIZER INC.
$252
BOSTON SCIENTIFIC CORPORATION
$197
TOLMAR Pharmaceuticals, Inc.
$165
Antares Pharma, Inc.
$162
Sumitomo Pharma America, Inc.
$151
Olympus America Inc.
$131
Tolmar, Inc.
$114
Bayer HealthCare Pharmaceuticals Inc.
$109
Medtronic, Inc.
$104
KARL STORZ Endoscopy-America
$97
Janssen Scientific Affairs, LLC
$96
Myriad Genetic Laboratories, Inc.
$85
Amgen Inc.
$82
UROVANT SCIENCES INC
$81
Dendreon Pharmaceuticals LLC
$57
Supernus Pharmaceuticals, Inc.
$54
ABBVIE INC.
$52
Allergan, Inc.
$51
Progenics Pharmaceuticals, Inc.
$44
ACCORD HEALTHCARE, INC.
$44
Merck Sharp & Dohme LLC
$39
Endo USA, Inc.
$38
ConvaTec Inc.
$37
Ferring Pharmaceuticals Inc.
$36
Kerecis Limited
$33
AbbVie Inc.
$33
Allergan Inc.
$31
Wilmington Medical Supply, Inc.
$28
Mission Pharmacal Company
$25
PROGENICS PHARMACEUTICALS, INC.
$24
Accord Healthcare, Inc.
$22
AstraZeneca Pharmaceuticals LP
$21
Tempus AI, Inc
$20
BIOPROTECT MEDICAL, INC.
$20
180 Medical, Inc.
$19
AbbVie, Inc.
$16
UroGen Pharma, Inc.
$14
COLOPLAST CORP
$13
Axonics Modulation Technologies, Inc.
$13
Blue Earth Diagnostics Limited
$13
Top 3 companies account for 50.3% of total payments
Associated products mentioned in payments ›
4mm · ADSTILADRIN · AMS · AMS 700 · AMS 700 CXR RTE KIT · AMS 700 CXR RTE Kit · AMS Ambicor · AQUABEAM ROBOTIC SYSTEM · AVEED · Axonics · Axonics r-SNM System · Axumin · BIOPROTECT BALLOON IMPLANT SYSTEM · BOTOX · BRACAnalysis · Bard Urinary Drainage Bag · Bulkamid · CAMCEVI · CURE CATHETER · EDEX · ELIGARD · ERLEADA · Erleada · GEMTESA · GENERAL BPH · GENERAL THERAPIES · GENERAL - KIDNEY STONE DISEASE · GENERAL - THERAPIES · GENERAL BPH · GENTLECATH GLIDE · GREENLIGHT · GREENLIGHT HOPKINS II OPTIK 30 · General - BPH · IMFINZI · INTERSTIM · INTERSTIM ICON · JELMYTO · KEYTRUDA · Kerecis Omega3 SurgiClose · LITHOVUE · LYNPARZA · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Nubeqa · OTREXUP · Otrexup · PROVENGE · PYLARIFY · Prolaris · Prolia · RED RUBBER · REZUM · SPACEOAR VUE · SpaceOAR · Spectra · SpeediCath · TITAN · TLANDO · TOVIAZ · Titan · UROLIFT · UROLIFT SYSTEM · Uribel · UroLift · UroLift ATC System · UroLift System · VORTEK · XIAFLEX · XTANDI · XYOSTED · Xtandi · ZYTIGA · eCoin Device Kit · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (79%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $255 per 100 Medicare services performed
Looking for an urology physician in Fort Myers?
Compare urology physicians in the Fort Myers area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
39
Per 100K population
4.9
County median income
$73,099
Nearest hospital
LEE MEMORIAL HOSPITAL
8.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Caesar is a clinical cardiology specialist, with above-average Medicare volume (top 16% in FL), with low-engagement industry engagement in the top 12% of FL peers, with 16 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Caesar experienced with automated urinalysis?
Based on Medicare claims data, Dr. Caesar performed 2,076 automated urinalysis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Caesar receive payments from pharmaceutical companies?
Yes. Dr. Caesar received a total of $19,400 from 55 companies across 422 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Caesar's costs compare to other urology physicians in Fort Myers?
Dr. Caesar's average Medicare payment per service is $57. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Caesar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →